Lydia M Balz

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
HER2 signalling by heterodimerisation with EGFR and HER3 in breast cancer is associated with worst outcome of the afflicted patients, which is attributed not only to the aggressiveness of such tumours but also to therapy resistance. Thus, in the present study we investigated the role of EGFR, HER2 and HER3 lateral signalling in cell migration by applying(More)
  • 1